Concordance of Actionable Mutations in Liquid Biopsies and Matched Tumor Tissue of Brazilian Nonsmall Cell Lung Cancer (NSCLC)

被引:0
|
作者
Silva, Marcela de Oliveira [1 ]
dos Reis, Mariana Bisarro [1 ]
Pinto, Icaro Alves [1 ]
Pontes, Natalia Zampieri [1 ]
Chiarantano, Rodrigo Sampaio [1 ]
De Marchi, Pedro [2 ]
Ferreira Da Silva, Flavio Augusto [5 ]
Evangelista, Adriane Feijo [1 ]
Reis, Rui Manuel [1 ,3 ,4 ]
Leal, Leticia Ferro [1 ,6 ]
机构
[1] Barretos Canc Hosp, Mol Oncol Res Ctr, Barretos, Brazil
[2] Oncoclin, Rio De Janeiro, Brazil
[3] Univ Minho, Life & Hlth Sci Res Inst ICVS, Braga, Portugal
[4] ICVS 3Bs, Govt Associate Laborator, Braga, Portugal
[5] Barretos Canc Hosp, Dept Clin Oncol, Barretos, Brazil
[6] Barretos Sch Med Paulo Prata FACISB, Barretos, Brazil
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PP.20
引用
收藏
页码:S16 / S16
页数:1
相关论文
共 50 条
  • [31] KRAS Mutation Status in Primary Nonsmall Cell Lung Cancer and Matched Metastases
    Cortot, Alexis B.
    Italiano, Antoine
    Burel-Vandenbos, Fanny
    Martel-Planche, Ghyslaine
    Hainaut, Pierre
    CANCER, 2010, 116 (11) : 2682 - 2687
  • [32] Clinical Relevance of Liquid Biopsies in Metastatic Adenocarcinoma of Non-small Cell Lung Cancer (NSCLC)
    Chougule, A.
    Chandrani, P.
    Pange, P.
    Kale, S.
    Jagtap, V.
    Noronha, V.
    Joshi, A.
    Patil, V.
    Dutt, A.
    Prabhash, K.
    Banavali, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2019, 21 (06): : 1131 - 1131
  • [33] Concordance of driver mutations in primary and matched metastasis from patients with non-small cell lung cancer (NSCLC) using next-generation sequencing (NGS).
    Vignot, Stephane
    Frampton, Garrett
    Yelensky, Roman
    Brambilla, Christian
    Toffart, Anne-Claire
    Miller, Vincent A.
    Palmer, Gary A.
    Cronin, Maureen T.
    Lazar, Vladimir
    Soria, Jean-Charles
    Stephens, Philip
    Brambilla, Elisabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [34] Characterization of TP53 mutations in actionable driver-negative non-small cell lung cancer (NSCLC)
    Chi, Jie
    Gandhi, Nishant
    Halmos, Balasz
    Liu, Stephen V.
    Ma, Patrick C.
    Elliott, Andrew
    Vanderwalde, Ari M.
    Mamdani, Hirva
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [35] The Emerging Role of "Liquid Biopsies," Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
    Esposito, Angela
    Criscitiello, Carmen
    Trapani, Dario
    Curigliano, Giuseppe
    CURRENT ONCOLOGY REPORTS, 2017, 19 (01)
  • [36] The Emerging Role of “Liquid Biopsies,” Circulating Tumor Cells, and Circulating Cell-Free Tumor DNA in Lung Cancer Diagnosis and Identification of Resistance Mutations
    Angela Esposito
    Carmen Criscitiello
    Dario Trapani
    Giuseppe Curigliano
    Current Oncology Reports, 2017, 19
  • [37] COMBINED CHEMORADIOTHERAPY IN STAGE IIIA, IIIB NONSMALL CELL LUNG-CANCER (NSCLC)
    PANOUSAKI, E
    PANTELAKOS, P
    KARPASITIS, N
    SAMANTAS, E
    ZABOGLOU, N
    SKARLOS, DV
    JOURNAL OF CHEMOTHERAPY, 1993, 5 : 706 - 706
  • [38] Epithelial to mesenchymal transition (EMT) changes in patients with nonsmall cell lung cancer (NSCLC)
    Lu, Wenying
    Chia, Collin
    Larby, Josie
    Haug, Greg
    Hardikar, Ashutosh
    Singhera, Gurpreeet Kaur
    Hackett, Tillie L.
    Robertson, Iain
    Eapen, Mathew Suji
    Sohal, Sukhwinder Singh
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [39] Screening for activating EGFR mutations in surgically resected nonsmall cell lung cancer
    Sriram, K. B.
    Tan, M. E.
    Savarimuthu, S. M.
    Wright, C. M.
    Relan, V.
    Stockwell, R. E.
    Clarke, B. E.
    Duhig, E. E.
    Yang, I. A.
    Bowman, R. V.
    Fong, K. M.
    EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (04) : 903 - 910
  • [40] Screening of gene mutations associated with bone metastasis in nonsmall cell lung cancer
    Zhang, Kun
    Zhang, Min
    Zhu, Jinlong
    Wang, Hong
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2016, 12 (07) : C186 - C190